Zobrazeno 1 - 10
of 4 766
pro vyhledávání: ''
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:122-131
Background: Gastric cancer (GC) is a common tumor found worldwide, and cisplatin is the first-line agent for the treatment of GC. However, the resistance to cisplatin is an obstacle. Here, we aim to explore the biological mechanism of long noncoding
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:132-139
Background: The procancer effect of TEA domain transcription factor 4 (TEAD4) has been gradually discovered. However, its expression in esophageal cancer (EC) cells and its effect on proliferation ...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:927-938
Background: Colorectal cancer (CRC) is a significant public problem and the third cause of cancer-induced death all over the world. In addition, long noncoding RNA (lncRNA) has been reported as a vital mediator in human cancer. However, the precise r
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:955-962
Objectives: With the aging population worldwide, the octogenarians are becoming a substantial group and since cancer incidence increases by age, this group of patients is becoming more affected. Ho...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:871-881
Background: Colorectal cancer (CRC) is the third most common malignancy worldwide. Matrine can act as a potential antitumor drug, and its antitumor activities have been tested in various cancers, including CRC. However, the effect of matrine and the
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:815-823
Background: Endometrial cancer (EC) is an intractable gynecological cancer with increasing incidence and mortality worldwide. Accumulating studies indicated that long noncoding RNA nuclear enriched...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:624-635
Objective: To investigate the effect of miR-146a on the sensitivity of breast cancer cells to paclitaxel (PTX). Materials and Methods: The mRNA expressions of miR-146a in normal breast cancer cells...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:662-672
Background: Long non-coding RNA actin filament-associated protein1-antisense RNA 1 (AFAP1-AS1) was confirmed to be associated with tumorigenesis. However, the role of AFAP1-AS1 in breast cancer was...
Long Noncoding RNA NEAT1 Promotes the Progression of Breast Cancer by Regulating miR-138-5p/ZFX Axis
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:636-649
Background: Growing evidence demonstrated that long noncoding RNAs (lncRNAs) were involved in the progression of diverse cancers, including breast cancer (BC). Recent studies indicated that lncRNA ...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:650-661
Background: Breast cancer is one of the most prevalent cancers that often occur in females. Long noncoding RNA differentiation antagonizing nonprotein coding RNA (DANCR) has been involved in the pathogenesis of various tumors, including breast cancer